SG Hiscock and Company say the Omicron variant has not stifled their four investment themes and may instead present opportunities for their positionings....
It will invest in Australian medical technology companies, with a social impact focus....
After decades of underperformance, value is seeing a turnaround and outpacing growth stocks for the first time in years, writes Laura Dew....
It would be a mistake to assume inflation will remain low, writes Hamish Tadgell, so advisers need to position portfolios to protect against this threat....
With the exception of the Global Financial Crisis, most cycles required only a three-year earnings recovery, according to SG Hiscock....
The reporting season has highlighted the divergence between firms with resilient business models, quality brand names, and the ability to capitalise on online demand, and...
trustees are already requesting such confirmations when advisory fees (even via fixed term agreements) are deducted from...
CSLR should be broken down into 2 sub sectors, one for product manufacturers and one for financial advisers. Product ma...
We must stand up and show our opposition to both the ASIC Levy and CSLR as they both contribute to the high cost of advi...